ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK - GSK (NYSE:GSK)
- Rosen Law Firm reminds GSK plc investors of the April 7, 2025 deadline to join a securities class action regarding ADR purchases from February 5, 2020, to August 14, 2022.
- GSK's withdrawal of Zantac is linked to undisclosed internal studies about its liability, according to the lawsuit.
- The complaint alleges that GSK misled investors by stating it removed Zantac based on available information and no causal link to cancer.
Insights by Ground AI
Does this summary seem wrong?
26 Articles
26 Articles
All
Left
2
Center
7
Right
5
Coverage Details
Total News Sources26
Leaning Left2Leaning Right5Center7Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
14%
C 50%
R 36%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage